Pancreatic Cell News Volume 2.34 | Aug 30 2011

    0
    34

    Pancreatic Cell News 2.34, August 30, 2011

         In this issue: PublicationsIndustry News | Policy News | Events | Jobs 
    Cell Therapy News on Facebook  Pancreatic Cell News on Twitter

    TOP STORY

    New Study Shows Zinc Suppresses Pancreatic Cancer Cells
    The essential element zinc has been shown in a new study to be a likely tumor suppressor in the most common form of pancreatic cancer. [Press release from the University of Maryland, Baltimore discussing online prepublication in Cancer Biology & Therapy] Press Release   | Abstract  

    ON192-PSC_TrainingSING_645x110  

    PUBLICATIONS (Ranked by Impact Factor of the Journal)

    DIABETES

    A Genetically Engineered Human Pancreatic β Cell Line Exhibiting Glucose-Inducible Insulin Secretion
    Here, investigators describe a robust technology for producing a functional human β cell line using targeted oncogenesis in human fetal tissue. [J Clin Invest] Abstract 

    Inhibitors of Src and Focal Adhesion Kinase Promote Endocrine Specification: Impact on the Derivation of Beta Cells from Human Pluripotent Stem Cells
    In this study researchers show that the pyrrolo-pyrimidine src-family kinase inhibitor PP2 effectively promotes the endocrine specification of human embryonic stem cell derivatives based on its capacity to induce the expression of proendocrine transcription factors (NGN3, NEUROD1, NKX2.2 and PAX4) and to significantly increase the final yield of insulin-positive cells. [J Biol Chem] Abstract 

    Elimination of the NLRP3-ASC Inflammasome Protects Against Chronic Obesity-Induced Pancreatic Damage
    This study provides direct in vivo evidence that activation of the Nod-like receptor family, pyrin domain containing 3 (Nlrp3) inflammasome in diet-induced obesity is a critical trigger in causing pancreatic damage and is an important mechanism of progression toward type 2 diabetes. [Endocrinology] Abstract 

    Thiamin Uptake by Pancreatic Acinar Cells: Effect of Chronic Alcohol Feeding/Exposure
    The results demonstrate for the first time that thiamin uptake by pancreatic acinar cells is via a carrier-mediated process, and that both the thiamin transporter-1 (THTR-1) as well as THTR-2 are expressed in these cells. [Am J Physiol Gastrointest Liver Physiol] Abstract 

    Immunomodulation and Regeneration of Islet Beta Cells by Cytokines in Autoimmune Type 1 Diabetes
    Cytokines both induce and regulate type 1 diabetes and have the potential to regenerate and preserve insulin-producing ß cells in the islets. [J Interferon Cytokine Res] Abstract 

    PANCREATIC CANCER

    c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
    In pancreatic tumors established in NOD SCID mice, c-Met inhibitors slowed tumor growth and reduced the population of cancer stem cells, when given alone or in combination with gemcitabine. [Gastroenterology] Abstract 

    Cellular Features of Senescence During the Evolution of Human and Murine Ductal Pancreatic Cancer
    Here, researchers have characterized a panel of potential oncogene-induced senescence biomarkers in human and murine pancreatic intraepithelial neoplasia, and found that only senescence-associated β-galactosidase activity is specifically enriched in these precursors, compared with pancreatic ductal adenocarcinoma. [Oncogene] Abstract 

    Inhibition of Chronic Pancreatitis and Pancreatic Intraepithelial Neoplasia (PanIN) by Capsaicin in LSL-KrasG12D/Pdx1-Cre Mice
    In this study, the effect of capsaicin on pancreatitis and pancreatic intraepithelial neoplasia was determined in a mutant Kras-driven and caerulein-induced pancreatitis-associated carcinogenesis in LSL-KrasG12D/Pdx1-Cre mice. [Carcinogenesis] Abstract 

    Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-Line Gemcitabine-Based Chemotherapy
    Researchers retrospectively studied 136 pancreatic cancer patients with available formalin-fixed paraffin-embedded tumor blocks from 2003 to 2009 to understand the clinical significance of KRAS mutations in pancreatic cancer patients treated with gemcitabine-based chemotherapy. [Mol Cancer Ther] Abstract 

    Mitochondrial DNA Copy Number and Pancreatic Cancer in the Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC) Study
    To test whether higher mitochondrial DNA copy number is associated with increased incident pancreatic cancer, scientists conducted a nested case-control study in the Alpha-Tocopherol Beta Carotene Cancer Prevention Study cohort of male smokers, aged 50-69 years at baseline. [Cancer Prev Res] Abstract 

    ON144-FreeTShirt_645x110 

    INDUSTRY NEWS

    Abbott Japan and Eisai Announce Launch of Pancreatic Digestive Enzyme Replacement Drug Lipacreon® (pancrelipase)
    Abbott Japan Co., Ltd. and Eisai Co., Ltd. announced that they will launch the pancreatic digestive enzyme replacement drug Lipacreon® Capsules 150 mg and Lipacreon® Granules 300mg Sachets (pancrelipase) on August 30 in Japan. [Eisai Co., Ltd. Press Release] Press Release

    Clavis Pharma Second Quarter and First Half Report 2011
    Clavis Pharma ASA announced its results for the second quarter and the first half 2011 (three and six months ended June 30, 2011). [Clavis Pharma ASA Press Release] Press Release

    Amsterdam Molecular Therapeutics Reports Half-Year Results 2011
    Amsterdam Molecular Therapeutics reported its results for the first half year of 2011. [Amsterdam Molecular Therapeutics Press Release] Press Release

    POLICY NEWS

    National Institutes of Health (United States)

    Food and Drug Administration (United States)
     
    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    National Health Service (United Kingdom)

    Therapeutic Goods Administration (Australia)

    EVENTS

    NEW 2nd Annual “Cancer Immunotherapy: A Long-Awaited Reality” Conference
    October 6, 2011
    New York, United States

    Visit our events page to see a complete list of events in the pancreatic cell community.

    JOB OPPORTUNITIES
    Lab Technologist – Tissue Culture (STEMCELL Technologies)

    Research and Development Technologist, hPSC Media (STEMCELL Technologies) 

    Scientist (iPSC) (STEMCELL Technologies)

    Contract Assay Service Technologist (STEMCELL Technologies) 

    Research and Development Technologist (STEMCELL Technologies) 

    Senior Scientific Advisor for Clinical & Translational Research (The National Institute of Diabetes and Digestive and Kidney Diseases)

    Postdoctoral Fellow in Cardiovascular/Diabetic Research (Boston University)

    Recruit Top Talent
    Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

    Jobs are categorized regionally: United States, Canada, Europe, Asia Pacific Visit here to post your career opportunities.

    Have we missed an important article or publication in Pancreatic Cell News? Click here to submit! 

    Comments or Suggestions? Email info@connexoncreative.com  with your feedback.

    Learn more about Pancreatic Cell News: Archives | Events | Contact Us